Up a level |
Kennedy, Nicholas A, Jones, Gareth-Rhys, Lamb, Christopher A, Appleby, Richard, Arnott, Ian, Beattie, R Mark, Bloom, Stuart, Brooks, Alenka J, Cooney, Rachel, Dart, Robin J et al (show 26 more authors)
(2020)
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
GUT, 69 (6).
pp. 984-990.
Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg-Bartolo, Simon et al (show 11 more authors)
(2022)
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55 (7).
pp. 856-866.
Lenti, Marco Vincenzo, Levison, Scott, Eliadou, Elena, Willert, Robert, Kemp, Karen, Carter, Anna, Stansfield, Catherine, Assadsangabi, Arash, Singh, Salil, Crooks, Ben et al (show 13 more authors)
(2018)
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
DIGESTIVE AND LIVER DISEASE, 50 (12).
pp. 1299-1304.